CollPlant Biotechnologies (CLGN) Asset Utilization Ratio (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Asset Utilization Ratio came in at 0.19 in Q4 2025, up 246.72% YoY from 0.05 in Q4 2024, and up 21.42% on a QoQ basis from 0.16 in Q3 2025.
CollPlant Biotechnologies (CLGN) Asset Utilization Ratio (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 8 years of Asset Utilization Ratio data on file, last reported at 0.19 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 246.72% year-over-year to 0.19 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.19 (up 246.72% YoY) and the FY2025 annual result came in at 0.16, up 724.72% from the prior year.
- Asset Utilization Ratio rose to 0.19 in Q4 2025, from 0.16 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 3233.58 in Q2 2024 to a low of 0.01 in Q4 2022.
- A 5-year average of 608.45 and a median of 0.28 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 18160145.53% — and 2024, when it slumped 100.0%.
- Tracing CLGN's Asset Utilization Ratio over 5 years: stood at 0.3 in 2021, then slumped by 95.35% to 0.01 in 2022, then soared by 18160145.53% to 2517.94 in 2023, then tumbled by 100.0% to 0.05 in 2024, then soared by 246.72% to 0.19 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.19 (Q4 2025), 0.16 (Q3 2025), and 0.05 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | CollPlant Biotechnologies | 4.33 Mn | 4.33 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | 0.16 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 3,233.58 |
| Mar 31, 2024 | 2,518.46 |
| Dec 31, 2023 | 2,517.94 |
| Sep 30, 2023 | 2,067.49 |
| Jun 30, 2023 | 0.28 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.03 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | 0.77 |
| Mar 31, 2021 | 3.94 |
| Dec 31, 2020 | 0.64 |
| Sep 30, 2020 | 0.16 |
| Jun 30, 2020 | 0.21 |